
浏览全部资源
扫码关注微信
首都医科大学附属北京中医医院急诊科,北京 100010
徐光勋,男,50岁,博士研究生,主治医师。研究方向:中医药在急危重症中的应用和机制。
纸质出版日期:2025-01-25,
收稿日期:2024-04-07,
移动端阅览
徐光勋, 张红升, 曹迎, 等. 乌梅丸治疗脓毒症合并腹泻及胃肠功能障碍的临床疗效观察[J]. 北京中医药, 2025,44(1):53-56.
XU GUANGXUN, ZHANG HONGSHENG, CAO YING, et al. Clinical efficacy of Wumei Pills in the treatment of diarrhea and gastrointestinal dysfunction in sepsis patients. [J]. Beijing journal of traditional chinese medicine, 2025, 44(1): 53-56.
徐光勋, 张红升, 曹迎, 等. 乌梅丸治疗脓毒症合并腹泻及胃肠功能障碍的临床疗效观察[J]. 北京中医药, 2025,44(1):53-56. DOI: 10.16025/j.1674-1307.2025.01.011.
XU GUANGXUN, ZHANG HONGSHENG, CAO YING, et al. Clinical efficacy of Wumei Pills in the treatment of diarrhea and gastrointestinal dysfunction in sepsis patients. [J]. Beijing journal of traditional chinese medicine, 2025, 44(1): 53-56. DOI: 10.16025/j.1674-1307.2025.01.011.
目的
2
观察乌梅丸汤剂治疗脓毒症合并腹泻及胃肠功能障碍的临床疗效。
方法
2
选取2016年4月—2022年3月就诊于首都医科大学附属北京中医医院急诊科的64例脓毒症合并腹泻及胃肠功能障碍患者为研究对象,通过随机数字表法将患者分为观察组和对照组,各32例。2组均给予常规治疗,观察组在常规治疗基础上加乌梅丸汤剂口服、鼻饲或直肠滴注。2组疗程均为7 d。观察2组病死率、腹泻疗效、安全性,及治疗前后胃肠功能障碍评分、序贯器官衰竭(SOFA)、急性生理与慢性健康评分系统Ⅱ(APACHE Ⅱ)评分。
结果
2
观察组死亡5例(16.13%),对照组死亡9例(29.03%),2组病死率差异无统计学意义(
P>
0.05)。死亡
RR
为0.85(95%
CI
0.644~1.112)。观察组总有效率高于对照组(
P
<
0.05)。与治疗前比较,2组治疗后胃肠功能障碍评分、SOFA评分、APACHE Ⅱ评分均降低(
P
<
0.05),且观察组治疗后胃肠功能障碍评分、SOFA评分、APACHE Ⅱ评分均低于对照组(
P
<
0.05)。2组患者均未出现药物相关的不良反应,2组血常规及肝、肾功能均无异常改变。
结论
2
乌梅丸汤剂对脓毒症合并腹泻及胃肠功能障碍,有明显的胃肠保护作用,同时也能减轻患者整体病情严重程度。
Objective
2
To observe the clinical efficacy of Wumei Pills decoction in the treatment of sepsis complicated with diarrhea and gastrointestinal dysfunction.
Method
2
Patients with sepsis complicated by diarrhea and gastrointestinal dysfunction who visited the Emergency Department of Beijing Hospital of Traditional Chinese Medicine, Capital Medical University from April 2016 to March 2022 were enrolled and randomly divided into an observation group and a control group using a random number table. Both groups received conventional treatment, with the observation group additionally receiving Wumei Pills decoction orally, via nasogastric tube, or rectal drip. The treatment duration was 7 days for both groups. The mortality rate, diarrhea efficacy, safety, and changes in gastrointestinal dysfunction scores, sequential organ failure assessment (SOFA) scores, and acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) scores were observed before and after treatment.
Result
2
In the observation group, 5 deaths (16.13%) occurred, while in the control group, 9 deaths (29.03%) occurred. There was no statistically significant difference in mortality between the two groups (
P
>
0.05), and the relative risk of death was 0.85 (95% CI: 0.644–1.112). The overall effective rate in the observation group was higher than that in the control group (
P
<
0.05). Compared with the results before treatment, both groups showed a decrease in gastrointestinal dysfunction scores, SOFA scores, and APACHE Ⅱ scores after treatment (
P
<
0.05). Additionally, the observation group had significantly lower gastrointestinal dysfunction scores, SOFA scores, and APACHE Ⅱ scores than the control group after treatment (
P
<
0.05). No drug-related adverse reactions occurred in either group, and there were no significant changes in blood routine or liver and kidney function in either group.
Conclusion
2
Wumei Pills decoction has a significant gastrointestinal protective effect on patients with sepsis complicated by diarrhea and gastrointestinal dysfunction, and it also alleviates the overall severity of the patient's condition.
乌梅丸脓毒症腹泻胃肠功能障碍
Wumei Pillssepsisdiarrheagastrointestinal dysfunction
PERNER A, CECCONII M, CRONHJORT M, et al. Expert statementfor the management of hypovolemia in sepsis[J]. Intensive Care Med, 2018,44(6):791-798.
HU B, SUN R, WU A, et al. Severity of acute gastrointestinal injury grade is a predictor of all-cause mortality in critically ill patients: a multicenter, prospective, obsevational study[J]. Crit Care, 2017,21(1):188.
任建安,黎介寿.肠衰竭的认识与进展[J].中国实用外科杂志,2003,23(1):37-38.
SINGER M,DEUTSCHMAN CS,SEYMOUR CW,et al. The third international consensus definitions for sepsis and septic shock(Sepsis-3)[J].JAMA,2016,315(8): 801-810.
中国中西医结合学会急救医学专业委员会.重修“95庐山会议”多器官功能障碍综合征病情分期诊断及严重程度评分标准(2015)[J].中华危重病急救医学,2016(2):99-101.
马卫卫. 加味乌梅汤治疗寒热错杂型功能性腹泻的临床研究[D].济南:山东中医药大学,2012.
曹迎,刘琳,石嘉恒,等.胃肠复元法治疗脓毒症胃肠功能障碍的临床研究[J].中国中西医结合杂志,2019,39(8):943-948.
徐航,茹凌,陈海华,等.中医内外结合疗法治疗脓毒症胃肠功能障碍的临床研究[J].辽宁中医杂志,2024,51(1):126-129.
李军.大黄附子汤治疗危重脓毒症疗效及对患者胃肠功能改善研究[J].陕西中医,2019,40(6):718-721.
洪杏,陈一斌,张阿锦.乌梅丸治疗ICU抗生素相关性腹泻临床观察[J].光明中医,2022,37(15):2779-2782.
苏红宝,王妮娜.乌梅丸加减治疗慢性腹泻寒热错杂证26例临床观察[J].甘肃中医药大学学报,2022,39(6):52-55.
周辉霞,熊湘平,张璟宏.乌梅丸治疗慢性腹泻的临床疗效观察[J].中国民间疗法,2017,25(3):50-51.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备 11010102006710号